A multicenter, real-world cohort study: effectiveness and safety of Azvudine in hospitalized COVID-19 patients with pre-existing diabetes

IntroductionDuring the Omicron infection wave, diabetic patients are susceptible to COVID-19, which is linked to a poor prognosis. However, research on the real-world effectiveness and safety of Azvudine, a common medication for COVID-19, is insufficient in those with pre-existing diabetes.MethodsIn...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Yongjian Zhou, Zecheng Yang, Shixi Zhang, Donghua Zhang, Hong Luo, Di Zhu, Guangming Li, Mengzhao Yang, Xiaobo Hu, Guowu Qian, Guotao Li, Ling Wang, Silin Li, Zujiang Yu, Zhigang Ren
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2025-02-01
Schriftenreihe:	Frontiers in Endocrinology
Schlagworte:	COVID-19 Azvudine diabetes real-world effectiveness safety
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1467303/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!